raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:667662

Breast implant-associated anaplastic large cell lymphoma

Synonyms: Breast implant-associated ALCL · Seroma-associated ALCL

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adult, Elderly
Status
active

A rare T-cell non-Hodgkin lymphoma characterized clinically by tumor developing exclusively after exposure to textured breast implants, and arising typically from the periprosthetic capsule surrounding them. Despite being a hematological malignancy, it behaves as a solid tumor.

1

Names in Orphadata languages

10 of 12 languages
LangNameSynonyms
enBreast implant-associated anaplastic large cell lymphomaBreast implant-associated ALCL · Seroma-associated ALCL
frLymphome anaplasique à grandes cellules lié à un implant mammaireLACG associé à un implant mammaire · LACG associé à un sérome
deBrustimplantat-assoziiertes anaplastisches großzelliges LymphomBIA-ALCL · Serom-assoziiertes ALCL
esLinfoma anaplásico de células grandes asociado a implantes mamariosLACG asociado a implantes mamarios · LACG asociado a seroma
itLinfoma anaplastico a grandi cellule correlato alle protesi mammarieALCL correlato al sieroma · ALCL correlato alle protesi mammarie
nlAnaplastisch grootcellig lymfoom geassocieerd met borstimplantaatALCL geassocieerd met borstimplantaat · ALCL geassocieerd met seroom
ptLinfoma anaplásico de células grandes associado a implante mamárioALCL associado a implante mamário · ALCL associado a seroma
plBreast implant-associated anaplastic large cell lymphoma= en
csAnaplastický velkobuněčný lymfom spojený s prsními implantáty= en
ukАнапластична великоклітинна лімфома, асоційована з грудним імплантатомАсоційована з грудними імплантатами ALCL · Серома-асоційована ALCL

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C84.7NTBTattributedvalidated
ICD-112A90.BNTBTindexvalidated
ICD-11XH05D8Especificvalidated
MONDO0850112Evalidated
MONDO850112Evalidated
UMLSC4528210Evalidated
MedDRA10082495Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

7 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
JAK1Disease-causing somatic mutation(s) inAssessedHGNC:6190ENSG000001624341477951p31.3Janus kinase 133660353[PMID]
STAT3Disease-causing somatic mutation(s) inAssessedHGNC:11364ENSG0000016861010258217q21.2signal transducer and activator of transcription 330546832[PMID]
BRCA1Major susceptibility factor inAssessedHGNC:1100ENSG0000001204811370517q21.31BRCA1 DNA repair associated40512039[PMID]
BRCA2Major susceptibility factor inAssessedHGNC:1101ENSG0000013961860018513q13.1BRCA2 DNA repair associated40512039[PMID]
TP53Major susceptibility factor inAssessedHGNC:11998ENSG0000014151019117017p13.1tumor protein p5330546832[PMID]
JAK2Part of a fusion gene inAssessedHGNC:6192ENSG000000969681477969p24.1Janus kinase 233660353[PMID]
STAT3Part of a fusion gene inAssessedHGNC:11364ENSG0000016861010258217q21.2signal transducer and activator of transcription 333660353[PMID]
5

Prevalence and incidence

0 records

No prevalence record in this release.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card